0001140361-13-012289.txt : 20130313
0001140361-13-012289.hdr.sgml : 20130313
20130313160835
ACCESSION NUMBER: 0001140361-13-012289
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130311
FILED AS OF DATE: 20130313
DATE AS OF CHANGE: 20130313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morton Andrew C.
CENTRAL INDEX KEY: 0001498511
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 13687548
MAIL ADDRESS:
STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC.
STREET 2: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2013-03-11
0
0000722723
HANGER, INC.
HGR
0001498511
Morton Andrew C.
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
V.P.-Human Resources
Common Stock
2013-03-11
4
A
0
2500
0
A
21706
D
Common Stock
2013-03-12
4
S
0
625
29.6197
D
21081
D
The restricted stock being reported does not include the contingent right of the reporting person to receive up to 2,500 additional performance shares under the issuer's 2010 Omnibus Incentive Plan based on the achievement of certain performance targets for the fiscal year 2013.
The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares.
These shares were sold at a range of sale prices from $29.49 to $29.87. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares which total 2,500 shares of stock from an initial grant of 2,500 shares of restricted stock made on March 11, 2013; (ii) unvested restricted shares and fully vested shares which total 4,375 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 7, 2012; (iii) unvested restricted shares and fully vested shares which total 4,441 shares of stock from an initial grant of 4,900 shares of restricted stock made on March 25, 2011; and (iv) unvested restricted shares and fully vested shares which total 9,765 shares of stock from an initial grant of 12,000 shares of restricted stock made on June 21, 2010. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Andrew C. Morton
2013-03-13